Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract

Hong-Lin Cheng, Nan-Haw Chow, Tzong Shin Tzai, Yat-Ching Tong, Johnny Shinn Nan Lin, Shih-Huang Chan, Wen-Horng Yang, Chien Chen Chang, YungMing Lin

研究成果: Article

12 引文 (Scopus)

摘要

Background: Haphazard cell proliferation is a fundamental biologic defect in cancer. Thus, assessment of the growth fraction provides a valuable index of biological property for human neoplasm. Proliferating cell nuclear antigen (PCNA) expression has been used to estimate the growth fraction of human cancer, and its prognostic value. Information in transitional cell carcinoma (TCC) of the upper urinary tract, however, is very few. Materials and Methods: A total of 73 patients with TCC of the upper urinary tract was collected between July 1988 and December 1995 for this study. The labeling index of PCNA immunostaining was correlated with clinicopathologic factors and compared for its prognostic value with a median follow-up of 54 months. Results: The PCNA index was positively associated with histological grading, tumor stage and patient prognosis (P = 0.00, respectively). Multivariate analysis demonstrated that significant factors in relation to patient survival were tumor stage (P = 0.01), followed by PCNA index (P = 0.04) and gender of patients (P = 0.04). Multiple comparison revealed that PCNA index set at 0.30 had prognostic value in terms of patient survival (P = 0.00), and the risk of metachronous bladder recurrence (P = 0.02). Conclusion: Our data suggested that assessment of PCNA index may be used as an adjuvant prognostic factor for patients with TCC of the upper urinary tract.

原文English
頁(從 - 到)2789-2793
頁數5
期刊Anticancer Research
17
發行號4 A
出版狀態Published - 1997 九月 3

指紋

Transitional Cell Carcinoma
Proliferating Cell Nuclear Antigen
Urinary Tract
Neoplasms
Survival
Neoplasm Grading
Growth
Urinary Bladder
Multivariate Analysis
Cell Proliferation
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

引用此文

@article{2cc8169afdb64aa2b403105c0ac6935a,
title = "Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract",
abstract = "Background: Haphazard cell proliferation is a fundamental biologic defect in cancer. Thus, assessment of the growth fraction provides a valuable index of biological property for human neoplasm. Proliferating cell nuclear antigen (PCNA) expression has been used to estimate the growth fraction of human cancer, and its prognostic value. Information in transitional cell carcinoma (TCC) of the upper urinary tract, however, is very few. Materials and Methods: A total of 73 patients with TCC of the upper urinary tract was collected between July 1988 and December 1995 for this study. The labeling index of PCNA immunostaining was correlated with clinicopathologic factors and compared for its prognostic value with a median follow-up of 54 months. Results: The PCNA index was positively associated with histological grading, tumor stage and patient prognosis (P = 0.00, respectively). Multivariate analysis demonstrated that significant factors in relation to patient survival were tumor stage (P = 0.01), followed by PCNA index (P = 0.04) and gender of patients (P = 0.04). Multiple comparison revealed that PCNA index set at 0.30 had prognostic value in terms of patient survival (P = 0.00), and the risk of metachronous bladder recurrence (P = 0.02). Conclusion: Our data suggested that assessment of PCNA index may be used as an adjuvant prognostic factor for patients with TCC of the upper urinary tract.",
author = "Hong-Lin Cheng and Nan-Haw Chow and Tzai, {Tzong Shin} and Yat-Ching Tong and Lin, {Johnny Shinn Nan} and Shih-Huang Chan and Wen-Horng Yang and Chang, {Chien Chen} and YungMing Lin",
year = "1997",
month = "9",
day = "3",
language = "English",
volume = "17",
pages = "2789--2793",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 A",

}

TY - JOUR

T1 - Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract

AU - Cheng, Hong-Lin

AU - Chow, Nan-Haw

AU - Tzai, Tzong Shin

AU - Tong, Yat-Ching

AU - Lin, Johnny Shinn Nan

AU - Chan, Shih-Huang

AU - Yang, Wen-Horng

AU - Chang, Chien Chen

AU - Lin, YungMing

PY - 1997/9/3

Y1 - 1997/9/3

N2 - Background: Haphazard cell proliferation is a fundamental biologic defect in cancer. Thus, assessment of the growth fraction provides a valuable index of biological property for human neoplasm. Proliferating cell nuclear antigen (PCNA) expression has been used to estimate the growth fraction of human cancer, and its prognostic value. Information in transitional cell carcinoma (TCC) of the upper urinary tract, however, is very few. Materials and Methods: A total of 73 patients with TCC of the upper urinary tract was collected between July 1988 and December 1995 for this study. The labeling index of PCNA immunostaining was correlated with clinicopathologic factors and compared for its prognostic value with a median follow-up of 54 months. Results: The PCNA index was positively associated with histological grading, tumor stage and patient prognosis (P = 0.00, respectively). Multivariate analysis demonstrated that significant factors in relation to patient survival were tumor stage (P = 0.01), followed by PCNA index (P = 0.04) and gender of patients (P = 0.04). Multiple comparison revealed that PCNA index set at 0.30 had prognostic value in terms of patient survival (P = 0.00), and the risk of metachronous bladder recurrence (P = 0.02). Conclusion: Our data suggested that assessment of PCNA index may be used as an adjuvant prognostic factor for patients with TCC of the upper urinary tract.

AB - Background: Haphazard cell proliferation is a fundamental biologic defect in cancer. Thus, assessment of the growth fraction provides a valuable index of biological property for human neoplasm. Proliferating cell nuclear antigen (PCNA) expression has been used to estimate the growth fraction of human cancer, and its prognostic value. Information in transitional cell carcinoma (TCC) of the upper urinary tract, however, is very few. Materials and Methods: A total of 73 patients with TCC of the upper urinary tract was collected between July 1988 and December 1995 for this study. The labeling index of PCNA immunostaining was correlated with clinicopathologic factors and compared for its prognostic value with a median follow-up of 54 months. Results: The PCNA index was positively associated with histological grading, tumor stage and patient prognosis (P = 0.00, respectively). Multivariate analysis demonstrated that significant factors in relation to patient survival were tumor stage (P = 0.01), followed by PCNA index (P = 0.04) and gender of patients (P = 0.04). Multiple comparison revealed that PCNA index set at 0.30 had prognostic value in terms of patient survival (P = 0.00), and the risk of metachronous bladder recurrence (P = 0.02). Conclusion: Our data suggested that assessment of PCNA index may be used as an adjuvant prognostic factor for patients with TCC of the upper urinary tract.

UR - http://www.scopus.com/inward/record.url?scp=0030755651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030755651&partnerID=8YFLogxK

M3 - Article

C2 - 9252716

AN - SCOPUS:0030755651

VL - 17

SP - 2789

EP - 2793

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 A

ER -